title: AAV5-mediated gene transfer to the parotid glands of non-human primates.
abstract: Salivary glands are potentially useful target sites for multiple clinical applications of gene transfer. Previously, we have shown that serotype 2 adeno-associated viral (AAV2) vectors lead to stable gene transfer in the parotid glands of rhesus macaques. As AAV5 vectors result in considerably greater transgene expression in murine salivary glands than do AAV2 vectors, herein we have examined the use of AAV5 vectors in macaques at two different doses (n = 3 per group; 10(10) or 3 x 10(11) particles per gland). AAV5 vector delivery, as with AAV2 vectors, led to no untoward clinical, hematological or serum chemistry responses in macaques. The extent of AAV5-mediated expression of rhesus erythropoietin (RhEpo) was dose-dependent and similar to that seen with an AAV2 vector. However, unlike results with the AAV2 vector, AAV5 vector-mediated RhEpo expression was transient. Maximal expression peaked at day 56, was reduced by approximately 80% on day 84 and thereafter remained near background levels until day 182 (end of experiment). Quantitative PCR studies of high-dose vector biodistribution at this last time point showed much lower AAV5 copy numbers in the targeted parotid gland (approximately 1.7%) than found with the same AAV2 vector dose. Molecular analysis of the conformation of vector DNA indicated a markedly lower level of concatamerization for the AAV5 vector compared with that of a similar AAV2 vector. In addition, cellular immunological studies suggest that host response differences may occur with AAV2 and AAV5 vector delivery at this mucosal site. The aggregate data indicate that results with AAV5 vectors in murine salivary glands apparently do not extend to macaque glands.
authors.affiliation: Molecular Physiology and Therapeutics Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD 20892-1190, USA.
authors.forename: A
authors.initials: A
authors.lastname: Voutetakis
authors.forename: C
authors.initials: C
authors.lastname: Zheng
authors.forename: A P
authors.initials: AP
authors.lastname: Cotrim
authors.forename: F
authors.initials: F
authors.lastname: Mineshiba
authors.forename: S
authors.initials: S
authors.lastname: Afione
authors.forename: N
authors.initials: N
authors.lastname: Roescher
authors.forename: W D
authors.initials: WD
authors.lastname: Swaim
authors.forename: M
authors.initials: M
authors.lastname: Metzger
authors.forename: M A
authors.initials: MA
authors.lastname: Eckhaus
authors.forename: R E
authors.initials: RE
authors.lastname: Donahue
authors.forename: C E
authors.initials: CE
authors.lastname: Dunbar
authors.forename: J A
authors.initials: JA
authors.lastname: Chiorini
authors.forename: B J
authors.initials: BJ
authors.lastname: Baum
mesh_terms: D000818:Animals; D000229:Dependovirus / Q000235:genetics*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors; D008253:Macaca mulatta; D010306:Parotid Gland / Q000378:metabolism* / Q000821:virology; D014161:Transduction, Genetic; D019076:Transgenes